Publications by authors named "Markku Viander"

Claim this Profile
C
Current laboratory and clinical practices in reporting and interpreting anti-nuclear antibody indirect immunofluorescence (ANA IIF) patterns: results of an international survey.
Lieve Van Hoovels, Sylvia Broeders, Edward K L Chan, Luis Andrade, Wilson de Melo Cruvinel, Markku Viander

Auto Immun Highlights· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An international survey on anti-neutrophil cytoplasmic antibodies (ANCA) testing in daily clinical practice.
Jan Damoiseaux, Ingmar Heijnen, Christel Van Campenhout, Catharina Eriksson, Nicole Fabien, Markku Viander

Clin Chem Lab Med· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and laboratory studies of the fate of intranasal allergen.
Janet Rimmer, Conceição Santos, Eija Yli-Panula, Virginia Noronha, Markku Viander

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From ANA-screening to antigen-specificity: an EASI-survey on the daily practice in European countries.
Jan Damoiseaux, Nancy Agmon-Levin, Marjan Van Blerk, Valentyna Chopyak, Catharina Eriksson, Markku Viander

Clin Exp Rheumatol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.
Nancy Agmon-Levin, Jan Damoiseaux, Cees Kallenberg, Ulrich Sack, Torsten Witte, Markku Viander

Ann Rheum Dis· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased risk of pertussis in adult patients with mannose-binding lectin deficiency.
Kirsi Gröndahl-Yli-Hannuksela, Markku Viander, Jussi Mertsola, Qiushui He

APMIS· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C4A deficiency in children and adolescents with recurrent respiratory infections.
Leena Kainulainen, Ville Peltola, Mikko Seppänen, Markku Viander, Qiushui He

Hum Immunol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene polymorphism in toll-like receptor 4: effect on antibody production and persistence after acellular pertussis vaccination during adolescence.
Kirsi Gröndahl-Yli-Hannuksela, Juho Vuononvirta, Alex-Mikael Barkoff, Markku Viander, Olivier Van Der Meeren

J Infect Dis· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age at development of type 1 diabetes- and celiac disease-associated antibodies and clinical disease in genetically susceptible children observed from birth.
Satu Simell, Sanna Hoppu, Tuu Simell, Marja-Riitta Ståhlberg, Markku Viander

Diabetes Care· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS.
Suvi P Kallio, Eveliina Jakkula, Shaun Purcell, Minna Suvela, Keijo Koivisto, Markku Viander

Hum Mol Genet· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fate of five celiac disease-associated antibodies during normal diet in genetically at-risk children observed from birth in a natural history study.
Satu Simell, Sanna Hoppu, Anne Hekkala, Tuula Simell, Marja-Riitta Ståhlberg, Markku Viander

Am J Gastroenterol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility.
Satu Simell, Antti Kupila, Sanna Hoppu, Anne Hekkala, Tuula Simell, Markku Viander

Scand J Gastroenterol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candida albicans-specific lymphoproliferative and cytokine (IL-4 and IFN-gamma) responses in atopic eczema dermatitis syndrome. Evidence of CD4/CD8 and CD3/CD16+CD56 ratio elevations in vitro.
Jan Kosonen, Marko Luhtala, Markku Viander, Kirsti Kalimo, Erkki O Terho

Exp Dermatol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence of cross-reactivity of human antibodies to a 33-mer peptide of the alpha-gliadin component of gluten with Bordetella pertussis pertactin.
Qiushui He, Matti K Viljanen, Ari E Hinkkanen, Heikki Arvilommi, Jussi Mertsola, Markku Viander

Vaccine· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis